- Home
- SMPL vs XENE Comparison
SMPL vs XENE Comparison
Compare SMPL & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMPL
- XENE
- Stock Information
- Founded
- SMPL 2017
- XENE 1996
- Country
- SMPL United States
- XENE Canada
- Employees
- SMPL N/A
- XENE N/A
- Industry
- SMPL Packaged Foods
- XENE Biotechnology: Pharmaceutical Preparations
- Sector
- SMPL Consumer Staples
- XENE Health Care
- Exchange
- SMPL Nasdaq
- XENE Nasdaq
- Market Cap
- SMPL 3.4B
- XENE 3.0B
- IPO Year
- SMPL 2016
- XENE 2014
- Fundamental
- Price
- SMPL $39.01
- XENE $41.15
- Analyst Decision
- SMPL Buy
- XENE Strong Buy
- Analyst Count
- SMPL 9
- XENE 10
- Target Price
- SMPL $39.67
- XENE $57.30
- AVG Volume (30 Days)
- SMPL 993.0K
- XENE 400.0K
- Earning Date
- SMPL 01-02-2025
- XENE 11-12-2024
- Dividend Yield
- SMPL N/A
- XENE N/A
- EPS Growth
- SMPL 4.55
- XENE N/A
- EPS
- SMPL 1.38
- XENE N/A
- Revenue
- SMPL $1,331,321,000.00
- XENE N/A
- Revenue This Year
- SMPL $11.84
- XENE N/A
- Revenue Next Year
- SMPL $6.18
- XENE $1,600.08
- P/E Ratio
- SMPL $28.27
- XENE N/A
- Revenue Growth
- SMPL 7.13
- XENE N/A
- 52 Week Low
- SMPL $30.00
- XENE $28.20
- 52 Week High
- SMPL $43.00
- XENE $50.99
- Technical
- Relative Strength Index (RSI)
- SMPL 74.26
- XENE 48.82
- Support Level
- SMPL $36.65
- XENE $37.34
- Resistance Level
- SMPL $39.54
- XENE $44.61
- Average True Range (ATR)
- SMPL 0.98
- XENE 1.85
- MACD
- SMPL 0.31
- XENE -0.39
- Stochastic Oscillator
- SMPL 90.33
- XENE 44.00
About SMPL The Simply Good Foods Company
The Simply Good Foods Co is a consumer packaged food and beverage company. It provides low-carbohydrate, high protein bars, shakes, and other products such as confections, chips, and cookies under the Atkins and Quest brands. The company distributes its products in retail channels, predominantly in North America, including grocery, club, and mass merchandise, as well as through e-commerce, convenience, and other channels.
About XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a clinical-stage biopharmaceutical company committed to developing therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system, or CNS, conditions. The product candidates of the group include XEN1101, XEN901, and XEN496 for Epilepsy, and Nav1.7 oral inhibitors for Pain. Geographically the activities are carried out throughout Canada.